Study antibiotic levels in heart valve infection
Part of Heart & circulation clinical trials.
This trial measures how your body handles certain intravenous antibiotics used for endocarditis, an infection of the heart valves. It may help doctors understand the best antibiotic dosing for people with valve infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed or suspected infection of a natural or replacement heart valve (endocarditis)
- The infection is in the left or right side of the heart
- You are receiving IV antibiotics such as ampicillin, penicillin G, cefotaxime, or cloxacillin
- You agree to sign informed consent to join the study
- You are age 18 or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a treatment without rifampin works as well as one with rifampin for a type of heart valve infection caused by staph bacteria. It aims to find a simpler and safer option for patients with an infected artificial heart valve.
This study looks at blood and other lab test results (“biomarkers”) to better predict what may happen to people with infective endocarditis, a serious infection of the heart lining or heart valves. Your information may help doctors estimate risk and choose care more safely and effectively.
This is an observational study that follows people with confirmed infective endocarditis (a serious infection of the heart lining or heart valves). It may help doctors better understand the illness and improve care.
This study gathers information from patients with a heart infection called endocarditis to help doctors better understand and treat the condition. Anyone aged 16 or older with confirmed or suspected endocarditis who is being treated at Barts Heart Centre may be able to join.
This study tests whether an FDG-PET/CT scan (a special imaging test) can help doctors choose the best treatment plan for people with a suspected native heart valve infection. It may help reduce uncertainty by showing where the infection activity is.
This study keeps a detailed record of adults with infective endocarditis (a serious heart valve infection) who are undergoing cardiac surgery. The information may help doctors understand patterns of care and outcomes, and improve future treatment decisions.
Hear when a new Infective Endocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.